from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2252/-

LFCtreatmentdescriptionclass of inhibitor

-1.760

Amikacinug/mL Amikacintranslation

-0.397

Cap5-10ug/mL Capreomycintranslation

-0.537

Rox10-50 ug/mL Roxithromycintranslation

0.850

SM2-5 ug/mL Streptomycintranslation

-1.387

Tet5-10 ug/mL Tetracyclinetranslation

0.145

Rif0.2-5ug/mL Rifampicintranscription

0.442

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.767

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.232

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.150

CPZ10-50 ug/mL Chlorpromazinerespiration

0.488

Clofazimine10-13 ug/mL Clofaziminerespiration

0.581

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.112

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.425

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.046

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.528

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.167

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.235

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.317

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.907

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.596

KCN5-20 ug/mL Potassium cyaniderespiration

0.721

NaN30.2-2 mM Sodium aziderespiration

0.409

Nigericin50 uM Nigericinrespiration

-0.529

TRC10-150 ug/mL Triclosanrespiration

-0.530

TRZ10-25 ug/mL Thioridazinerespiration

-0.253

Valinomycin0.5-10 uM Valinomycinrespiration

1.223

ZnSO42 mM ZnSO4respiration

1.490

menadione6-10 ug/mL Menadionerespiration

0.147

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.059

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.445

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.673

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.036

NRP_1Non-replicating persistence stage 1dosRassociated

0.189

Amp0.2mg/mL AmpicillincellWall

-0.103

Cephalexin20-100 ug/mL CephalexincellWall

0.379

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.153

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.096

EMB10-20 ug/mL EthambutolcellWall

-0.022

Eta12-40 ug/mL EthionamidecellWall

-0.210

INH0.2-0.4 ug/mL IsoniazidcellWall

0.326

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.006

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.320

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.078

BZA0.12 mg/mL BenzamidearomaticAmides

0.224

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.139

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.088

H2O24 mM hydrogen peroxideDNAdamaging

-0.141

Levo10 ug/mL LevofloxacinDNAdamaging

-0.223

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.061

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.918

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.019

UVUV-irradiationDNAdamaging

5.244

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.537

Antimycin12.5-50 ug/mL Antimycin A?

0.774

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.180

PA_110-50 ug/mL Antitubercular compound PA-1?

0.169

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.333

PA8240.2-2 ug/mL PA-824?

-0.645

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.810

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.116

Verapamil50 uM Verapamil?

0.370

mercaptoethanol2 mM 2-Mercaptoethanol?

0.825

methoxatin10-20 ug/mL Methoxatin?